Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus

Details for Australian Patent Application No. 2006213775 (hide)

International Classifications

Event Publications

30 August 2007 PCT application entered the National Phase

PCT publication WO2006/086561 Priority application(s): WO2006/086561

11 November 2010 Application Accepted

Published as AU-B-2006213775

24 February 2011 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 03 Feb 2011. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

14 July 2011 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 23 Jun 2011. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

3 November 2011 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 23 Jun 2011

10 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.